biomerica.png
Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
May 11, 2021 08:19 ET | Biomerica, Inc.
Less invasive nasal swab taken from front opening of the nose is more comfortable for patientsTest can be performed by doctors, school and company nurses, and medical assistants, in any location...
biomerica.png
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
April 15, 2021 10:31 ET | Biomerica, Inc.
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including...
biomerica.png
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
January 15, 2021 09:27 ET | Biomerica, Inc.
Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021  FDA actively reviewing Company’s EUA submission for its...
biomerica.png
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
January 12, 2021 08:19 ET | Biomerica, Inc.
Biomerica receives first orders and plans to ship tests in coming weeks  Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement...
biomerica.png
Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
December 09, 2020 08:19 ET | Biomerica, Inc.
Patient enrollment completion anticipated by the end of April 2021InFoods® Diagnostic-Guided Therapy is designed to address the $30 billion market for IBS treatmentTherapy seeks to identify...
biomerica.png
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
October 16, 2020 09:27 ET | Biomerica, Inc.
IRVINE, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August...
biomerica.png
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
September 01, 2020 08:19 ET | Biomerica, Inc.
Fiscal fourth quarter revenues increase 133.7% over the prior yearFiscal 2020 revenues increase 28.7% over fiscal 2019 New InFoods® patent granted for Singapore IRVINE, Calif., Sept. 01, 2020 ...
biomerica.png
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
August 31, 2020 08:19 ET | Biomerica, Inc.
IRVINE, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced today the retirement of Janet Moore, the Company’s Chief Financial Officer. After many years of...
biomerica.png
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
August 12, 2020 08:19 ET | Biomerica, Inc.
IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for Biomerica’s...
biomerica.png
Biomerica Announces Filing of New Three Year Shelf Registration Statement
July 22, 2020 06:39 ET | Biomerica, Inc.
IRVINE, Calif., July 22, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new three year shelf registration statement on Form S-3 with the United States...